1. Sateia MJ. International classification of sleep disorders. Chest 2014;146:1387-1394.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington DC: American Psychiatric Pub; 2013.
4. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017;26:675-700.
5. Chung S, Park B, Yi K, Lee J. Pattern of hypnotic drug prescription in South Korea: health insurance review and assessment service-national sample. Sleep Med Res 2013;4:51-55.
8. In: Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. , editor. AMIA annual symposium proceedings. American Medical Informatics Association, 2006, p. 359
9. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Intern Med 2016;165:125-133.
16. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychaitry Res 1989;28:193-213.
19. Glenville M, Broughton R. Reliability of the Stanford Sleepiness Scale compared to short duration performance tests and the Wilkinson Auditory Vigilance Task. Adv Biosci 1978;21:235-244.
22. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491.
23. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97-110.
24. Spoormaker VI, Verbeek I, van den Bout J, Klip EC. Initial validation of the SLEEP-50 questionnaire. Behav Sleep Med 2005;3:227-246.
25. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American academy of sleep medicine report. Sleep 2006;29:1415-1419.
26. Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009;13:205-214.
27. Morin CM. Cognitive-behavioral approaches to the treatment of insomnia. J Clin Psychiatry 2004;65(Suppl 16):33-40.
28. Sadock B, Ruiz P. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences. New York: Walters Kluwer; 2015.
29. Billioti de Gage S, Pariente A, Begaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf 2015;14:733-747.
30. Flurazepam, triazolam, flunitrazepam, and brotizolam. Available at:
www.druginfo.co.kr. Accessed August 10, 2018.
31. French DD, Spehar AM, Campbell RR, Palacios P, Coakley RW, Coblio N, et al. Outpatient Benzodiazepine Prescribing, Adverse Events, and Costs. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editor. Advances in Patient Safety: from Research to Implementation (Volume 1: Research Findings). Rockville, MD: Agency for Healthcare Research and Quality, 2005, p. 185-198.
32. MacFarlane J, Morin CM, Montplaisir J. Hypnotics in insomnia: the experience of zolpidem. Clin Ther 2014;36:1676-1701.
35. FDA requires lower dosing of zolpidem. Med Lett Drugs Ther 2013;55:5
36. Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007;23:2597-2605.
37. Yeung WF, Chung KF, Yung KP, Ng TH. Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 2015;19:75-83.
38. Jaffer KY, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci 2017;14:24-34.
39. Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS spectr 2009;14:536-546.
41. Yi XY, Ni SF, Ghadami MR, Meng HQ, Chen MY, Kuang L, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 2018;45:25-32.
42. Vande Griend JP, Anderson SL. Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc 2012;52:e210-e219.
45. Youn S, Han CC, Park B, Lee S, Yi K, Chung S. The effects of the new guidance ‘take your sleeping pills 7 h before your wake-up time’: a pilot study. Sleep Biol Rhythms 2016;14:397-404.
46. Chung S, Youn S, Park B, Lee S, Kim C. The effectiveness of prolongedrelease melatonin in primary insomnia patients with a regular sleepwake cycle. Sleep Med Res 2016;7:16-20.
47. Nam Y, Cho C, Lee Y, Lee H. Development of safety usage guidelines for sedative hypnotics using the Delphi technique. Sleep Med Psychophysiol 2019;26:2